Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection

Parasitology International - Tập 57 - Trang 506-508 - 2008
Luis G.C. Pacheco1,2, Vítor L.T. Mati3, Thiago L.P. Castro1, Fernanda A. Dorella1, Sérgio C. Oliveira2, Anderson Miyoshi1, Alan L. de Melo3, Vasco Azevedo1
1Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte – MG, Brazil
2Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil
3Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte – MG, Brazil

Tài liệu tham khảo

Chitsulo, 2004, Schistosomiasis, Nat Rev Microbiol, 2, 12, 10.1038/nrmicro801 Wilson, 2006, Schistosome vaccines: a critical appraisal, Mem Inst Oswaldo Cruz, 101, 13, 10.1590/S0074-02762006000900004 Capron, 2002, Prospects for a schistosome vaccine, Curr Drug Targets Immune Endocr Metab Disord, 2, 281, 10.2174/1568008023340587 Pearce, 2003, Progress towards a vaccine for schistosomiasis, Acta Trop, 86, 309, 10.1016/S0001-706X(03)00062-7 Bergquist, 2002, Blueprint for schistosomiasis vaccine development, Acta Trop, 82, 183, 10.1016/S0001-706X(02)00048-7 Kofta, 2001, c-DNA vaccination against parasitic infections: advantages and disadvantages, Vet Parasitol, 100, 3, 10.1016/S0304-4017(01)00478-2 Dupré, 1999, Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment, J Infect Dis, 180, 454, 10.1086/314875 Da'Dara, 2003, A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection, Parasite Immunol, 25, 429, 10.1111/j.1365-3024.2003.00651.x Chlichlia, 2001, DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice, Vaccine, 20, 439, 10.1016/S0264-410X(01)00345-0 Shalaby, 2003, Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes, Vaccine, 22, 130, 10.1016/S0264-410X(03)00535-8 Cook, 2004, Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage, Infect Immun, 72, 6112, 10.1128/IAI.72.10.6112-6124.2004 Fonseca, 2006, Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone, Microbes Infect, 8, 2509, 10.1016/j.micinf.2006.06.008 Nascimento, 2002, Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis, Mem Inst Oswaldo Cruz, 97, 105, 10.1590/S0074-02762002000900021 Dietrich, 1999, Delivery of DNA vaccines by attenuated intracellular bacteria, Immunol Today, 20, 251, 10.1016/S0167-5699(98)01431-5 Weiss, 2001, Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells, Biol Chem, 382, 533, 10.1515/BC.2001.067 Pacheco, 2005, Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis, Acta Trop, 95, 132, 10.1016/j.actatropica.2005.05.007 Sambrook, 2001 Pellegrino, 1956, Técnica de perfusão para colheita de Schistosoma mansoni em cobaias experimentalmente infectadas, Ver Bras Malariol D Trop, 8, 589 Donnelly, 2003, Technical and regulatory hurdles for DNA vaccines, Int J Parasitol, 33, 457, 10.1016/S0020-7519(03)00056-0 Andrade, 1964, Mild prolonged schistosomiasis: alterations in host response with time and the development of portal fibrosis, Trans R Soc Trop Méd Hyg, 58, 447 Sandor, 2003, Granulomas in schistosome and mycobacterial infections: a model of local immune responses, Trends Immunol, 24, 44, 10.1016/S1471-4906(02)00006-6 Wilson, 2007, Immunopathology of schistosomiasis, Immunol Cell Biol, 85, 148, 10.1038/sj.icb.7100014 Pellegrino, 1965, The oogram method for the screening of drugs in schistosomiasis mansoni, Am J Trop Med Hyg, 14, 363, 10.4269/ajtmh.1965.14.363 Pearce, 1991, Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni, J Exp Med, 173, 159, 10.1084/jem.173.1.159 Cheever, 1992, The role of cytokines in the pathogenesis of hepatic granulomatous disease in Schistosoma mansoni infected mice, Mem Inst Oswaldo Cruz, 87, 81, 10.1590/S0074-02761992000800011 Hoffmann, 2000, IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis, J Immunol, 164, 6406, 10.4049/jimmunol.164.12.6406